bexarotene has been researched along with fluorobenzenes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collado, A; Escudero, P; Gonzalez-Navarro, H; Hermenegildo, C; Martinez de Marañón, A; Peiró, C; Piqueras, L; Sanz, MJ | 1 |
1 other study(ies) available for bexarotene and fluorobenzenes
Article | Year |
---|---|
Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
Topics: Angiotensin II; Anticarcinogenic Agents; Arteries; Bexarotene; Cell Adhesion; Cell Line; Fluorobenzenes; Humans; Leukocytes, Mononuclear; Membrane Proteins; NADPH Oxidase 5; NADPH Oxidases; Nitric Oxide; Peroxisome Proliferator-Activated Receptors; Pyrimidines; Retinoid X Receptors; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Tetrahydronaphthalenes | 2015 |